key: cord-1050484-f5p37j7g
authors: Kissler, Stephen M.; Tedijanto, Christine; Goldstein, Edward; Grad, Yonatan H.; Lipsitch, Marc
title: Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
date: 2020-04-14
journal: Science
DOI: 10.1126/science.abb5793
sha: 68017de5b94decc227a91aa69169ad303cf1e074
doc_id: 1050484
cord_uid: f5p37j7g

It is urgent to understand the future of severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) transmission. We used estimates of seasonality, immunity, and cross-immunity for betacoronaviruses OC43 and HKU1 from time series data from the USA to inform a model of SARS-CoV-2 transmission. We projected that recurrent wintertime outbreaks of SARS-CoV-2 will probably occur after the initial, most severe pandemic wave. Absent other interventions, a key metric for the success of social distancing is whether critical care capacities are exceeded. To avoid this, prolonged or intermittent social distancing may be necessary into 2022. Additional interventions, including expanded critical care capacity and an effective therapeutic, would improve the success of intermittent distancing and hasten the acquisition of herd immunity. Longitudinal serological studies are urgently needed to determine the extent and duration of immunity to SARS-CoV-2. Even in the event of apparent elimination, SARS-CoV-2 surveillance should be maintained since a resurgence in contagion could be possible as late as 2024.

Data. Viral testing data came from the US National Respiratory and Enteric Virus Surveillance System (NREVSS) (31) . We extracted the weekly number of total tests for any coronavirus and positive tests for betacoronaviruses HCoV-OC43 and HCoV-HKU1 from all reporting laboratories between 5 th July 2014 and 29 th June 2019. Dividing the weekly number of positive tests by the total weekly number of tests yielded the weekly percentage of positive tests for each coronavirus.

To estimate the incidence of each betacoronavirus, we used an incidence proxy calculated by multiplying the weekly percentage of positive tests for each coronavirus by the weekly population-weighted proportion of physician visits due to influenza-like illness (ILI) (32) . The assumptions needed for this proxy to capture true influenza incidence up to a multiplicative constant are described in Goldstein et al. (32) . Since betacoronaviruses HCoV-OC43 and HCoV-HKU1 are more likely to cause milder cold-like symptoms or acute respiratory infection than ILI, our proxy additionally requires that the proportion of coronavirus cases with ILI is constant over the study period. The weekly proportions of ILI visits were obtained from the US Outpatient Influenza-like Illness Surveillance Network (ILINet) and accessed through the FluView Interactive website (33).

Estimating the impact of cross immunity and seasonal drivers of transmission. We used the effective reproduction number, defined as the average number of secondary infections caused by a single infected individual, to quantify the time-varying transmissibility of each coronavirus strain. We estimated the daily effective reproduction number (Ru) based on case counts and the generation interval distribution (34) , with the following parameterization (35) :

, where b(t) is the strain-level incidence proxy on day t, g(a) is the value of the generation interval distribution at time a, and imax is the maximum generation interval, set as the first day at which over 99% of generation interval distribution had been captured. The generation interval for the four commonly circulating coronaviruses has not been well-studied. In this analysis, we used the estimated serial interval distribution for SARS (Weibull with mean 8.4 days and standard deviation 3.8 days (58) ) and varied this assumption in sensitivity analyses based on observations that the serial interval for currently circulating human coronaviruses and SARS-CoV-2 may be considerably lower (39, 41) (Fig S2) .

To translate the weekly incidence proxies to measures of daily incidence, we followed a previously described spline-based procedure (36) . For smoothing, the final weekly R is the geometric mean of the daily values in the preceding, current, and following weeks (3- week moving average). We discarded the first three and last three weekly R estimates. To avoid unstable R estimates resulting from periods of low coronavirus activity, we limited our analysis to "in-season" estimates. Seasons were defined as To measure the relative contribution of depletion of susceptibles compared to seasonal forcing in the observed data, we adapted a linear regression model as follows (36): where Rsij is the weekly effective reproduction number for strain s in week i of season j, R0 is the basic reproduction number, S0 is the fraction of susceptibles at the start of the first season for the reference strain (HCoV-HKU1), and ϵsij is a normally distributed error term. A dummy variable for each additional strain-season combination (ɑsj) captures differences in the reproduction number and the starting fraction of susceptibles between strains and over time, but is unable to distinguish between the two. Both R0 and the fraction of susceptibles may vary by strain and season. If R0 is assumed to be similar at the start of each season and between the strains, then the dummy variables can be interpreted as differences in immunity. The next two terms estimate the impact of depletion of susceptibles due to infection by the same strain (dsij) and the other betacoronavirus strain (drij). Depletion of susceptibles for each strain was estimated up to a proportionality constant by the cumulative sum of the incidence proxy over season j through week i. The coefficient on the first term (λs) represents the scaling factor between the cumulative incidence proxy and true depletion of susceptibles, while δs captures the level of cross-immunity in addition to scaling; both coefficients were allowed to vary by strain. Because specific seasonal drivers (e.g. absolute humidity) of seasonal variation in coronavirus transmission have not been identified, we did not include them in our model but used a cubic basis spline with knots every four weeks to capture fluctuations in seasonal forcing over the year. Bn represents the ten basis functions for a cubic spline with seven internal knots and no intercept, and θn the coefficients corresponding to each of these functions. Dynamic transmission model. We implemented a two-strain ordinary differential equation (ODE) susceptible-exposed-infectious-recovered-susceptible (SEIRS) compartmental model to describe the transmission dynamics of HCoV-OC43 ('strain 1') and HCoV-HKU1 ('strain 2') in the United States.

Exposed individuals became infectious at rate ν and infectious individuals recovered at rate γ. Immunity waned at rates σ1 and σ2 for HCoV-OC43 and HCoV-HKU1, respectively. The basic reproduction number, R0, was assumed to be seasonal with a period of 52 weeks, specified by the equation where max(R0) is the maximum wintertime value of R0, f is the proportional decline in R0 that occurs in the summer (f=0 denotes constant R0 throughout the year), and Φ is the phase shift in weeks. We rounded the length of a year to 52 weeks. The transmission rate β(t) is related to the basic reproduction number by the formula (12) Cross immunity of HCoV-OC43 against HCoV-HKU1 was captured by χ1,2 such that the transmission rate of HCoV-HKU1 to an individual who is exposed to, infected with, or recovered from HCoV-OC43 was reduced by a factor of 1-χ1,2, and vice-versa. Individuals died at rate μ such that the average lifespan was 1/μ = 80 years. Fully susceptible individuals were born at the same rate μ to keep the population size constant. A schematic of the model structure is depicted in Fig S4. The entire population was assumed to be susceptible at the start of the simulation period (time = 0).

Infection was introduced through a brief, small pulse in the force of infection (an increase of 0.01/week for one half week) for each strain within the first year of the simulation, simulating the establishment of sustained person-to-person transmission. The model was run for 24.5 years to allow the dynamics to reach a steady state, and then the simulated incidence of Strain 1 and Strain 2 were compared with the percent test-positives multiplied by percent of clinic visits for ILI for HCoV-OC43 and HCoV-HKU1, respectively, after scaling the simulated prevalence by a factor ψ. This scaling factor accounts for the difference between % ILI times % positive tests (the units of the data) and the actual prevalence of infection. Model fit was assessed by the SSE between the data and the ψ-scaled simulated prevalence of infection for each strain after taking the logarithm of both. The SSE is proportional to the log likelihood, assuming normal-distributed errors. QQ-plots of the residuals between the data and the model fit support the assumption of normality ( Figure S5) . To determine the parameter values consistent with HCoV-OC43 and HCoV-HKU1 transmission, we used latin hypercube sampling (LHS) (59) to simulate transmission for 100,000 combinations of the model parameters sampled uniformly from the ranges reported in Table 1 . We then used the Nelder-Mead algorithm as implemented in Mathematica's "NMaximize" function to refine the minimum SSE estimate from the LHS sample. These parameter values are listed in Table S8 . We were unable to robustly estimate confidence intervals for the estimated parameters because the likelihood surface is jagged due to frequent bifurcations in the model solutions ( Figure S6) . These bifurcations arise due to the competition between strains, which can cause the phase of the outbreaks (e.g. whether major HCoV-OC43 outbreaks occur on even or odd years) to shift suddenly as the parameter values change. Instead, we note that the estimated parameter values lie in epidemiologically reasonable ranges, provide a good fit to the incidence data (Figure 2A Next, we incorporated a third strain into the dynamic transmission model to represent SARS-CoV-2, following the same structure as the model depicted in Figure S4 . We simulated transmission of HCoV-OC43 and HCoV-HKU1 for 20 years and then simulated the establishment of sustained SARS-CoV-2 transmission using another half-week pulse in the force of infection. We assumed that the latent period for SARS-CoV-2 was 4.6 days (37-39) and the infectious period was 5 days, informed by the estimates for the other betacoronaviruses (see Table S8 ). We allowed the cross immunity from SARS-CoV-2 to the other betacoronaviruses and vice-versa to range from 0 to 1, the duration of immunity to SARS-CoV-2 to range from 40 weeks to permanent, the seasonal variation in R0 to vary between none and 40%, and the establishment time to vary throughout 2020. To adjust the amount of seasonal variation in R0, we held the maximum wintertime value of the sinusoid fixed and adjusted the minimum summertime (baseline) value.

This way, smaller degrees of seasonal forcing translated into smaller summertime declines in R0; for the no-seasonality scenario, R0 was held fixed at its maximal wintertime value. This choice was informed by observations on the seasonal variation in R0 for influenza, for which the wintertime R0 was similar between geographic locations with distinct climates, while the summertime R0 varied substantially between locations (12) . For parameter values within these ranges, we measured the annual incidence of infection due to SARS-CoV-2 and the annual SARS-CoV-2 outbreak peak size for the five years following the simulated time of establishment (Tables S2-7, Figure S7 ). We summarized the postpandemic SARS-CoV-2 dynamics into the categories of annual outbreaks, biennial outbreaks, sporadic outbreaks, or virtual elimination (Tables S2-7) .

Single-strain transmission model with interventions. To study the qualitative range of social distancingbased interventions that might be effective in curbing SARS-CoV-2 transmission, we implemented an SEIR-type ODE model with a mild illness arm, a hospitalization arm, and a critical care arm. A diagram of the model is given in Figure S9 , with parameter values in the caption. Since the focus was on the initial pandemic wave, we did not consider waning immunity. We also ignored any cross immunity from the other coronavirus strains against SARS-CoV-2, so that our projections represent a worst-case scenario.

The model depicted in Figure S9 assumes exponentially-distributed waiting times in each compartment, which may not reflect the true distributions of the latent period, infectious period, or hospital stays. To assess the effect of non-exponential waiting times, we introduced four additional 'dummy' compartments into each internal state of the model (i.e. all states except 'susceptible' and 'recovered') so that the waiting times were gamma-distributed ( Figure S17 ). The exit rates from each compartment were multiplied by five so that the mean duration in each state remained the same as in the model with exponential waiting times. Table S1 . Estimated regression model coefficients. The intercept represents the natural log of the effective reproduction number (R0 times fraction susceptible) for HCoV-HKU1 at the start of the 2014-15 season, and each ɑsj parameter represents the difference in log effective reproduction number for strain s at the start of season j compared to this reference. The λs parameters represent the effect of the depletion of susceptibles of strain s (in incidence proxy units) on the effective reproduction number, and the δs parameters represent the effect of the depletion of susceptibles of the opposite strain. The θ parameters are the coefficients of the basis spline.

Intercept δs Table S2 . Simulated SARS-CoV-2 infections through 2025 with low seasonal forcing. Cumulative projected SARS-CoV-2 cases per 1,000 individuals by year for a representative set of cross immunities, immunity durations, and establishment times. The maximum wintertime R0 is 2.2 and the summertime R0 is diminished by a factor of 10% (R0 = 2.0). χ3X represents the degree of cross-immunity induced by infection with SARS-CoV-2 against OC43 and HKU1 and χX3 represents the degree of crossimmunity induced by OC43 or HKU1 infection against SARS-CoV-2. The establishment times correspond to: Winter -week 4 (early February); Spring -week 16 (late April); Summer -week 28 (mid July); Autumn -week 40 (early October). Darker shading corresponds to higher cumulative infection sizes. Years denote epidemiological years, so that 2020 refers to the months between July 2019 and June 2020. Table S3 . Simulated SARS-CoV-2 infections through 2025 with moderate seasonal forcing. Cumulative projected SARS-CoV-2 cases per 1,000 individuals by year for a representative set of cross immunities, immunity durations, and establishment times. The maximum wintertime R0 is 2.2 and the summertime R0 is diminished by a factor of 20% (R0 = 1.8). χ3X represents the degree of cross-immunity induced by infection with SARS-CoV-2 against OC43 and HKU1 and χX3 represents the degree of cross-immunity induced by OC43 or HKU1 infection against SARS-CoV-2. The establishment times correspond to: Winterweek 4 (early February); Spring -week 16 (late April); Summer -week 28 (mid July); Autumn -week 40 (early October). Darker shading corresponds to higher cumulative infection sizes. Years denote epidemiological years, so that 2020 refers to the months between July 2019 and June 2020. Table S4 . Simulated SARS-CoV-2 infections through 2025 with high seasonal forcing. Cumulative projected SARS-CoV-2 cases per 1,000 individuals by year for a representative set of cross immunities, immunity durations, and establishment times. The maximum wintertime R0 is 2.2 and the summertime R0 is diminished by a factor of 40% (R0 = 1.3). χ3X represents the degree of cross-immunity induced by infection with SARS-CoV-2 against OC43 and HKU1 and χX3 represents the degree of crossimmunity induced by OC43 or HKU1 infection against SARS-CoV-2. The establishment times correspond to: Winter -week 4 (early February); Spring -week 16 (late April); Summer -week 28 (mid July); Autumn -week 40 (early October). Darker shading corresponds to higher cumulative infection sizes. Years denote epidemiological years, so that 2020 refers to the months between July 2019 and June 2020. 1.3) . χ3X represents the degree of cross-immunity induced by infection with SARS-CoV-2 against OC43 and HKU1 and χX3 represents the degree of crossimmunity induced by OC43 or HKU1 infection against SARS-CoV-2. The establishment times correspond to: Winter -week 4 (early February); Spring -week 16 (late April); Summer -week 28 (mid July); Autumn -week 40 (early October). Darker shading corresponds to higher cumulative infection sizes. Years denote epidemiological years, so that 2020 refers to the months between July 2019 and June 2020. Epidemiological compartments are represented by the bold letter-number pairs, such that an individual in compartment S1S2 is susceptible to both strains, while a person in compartment I1E2 is infectious with strain 1 and has been exposed to strain 2. Filled circles represent death and the open circle represents births. Transition rates are given next to the arrows between compartments. Estimated parameter values are listed in Table S8 . (Table S8 ) and establishment is on 11 March 2020. High cross immunity from HCoVs OC43/HKU1 against SARS-CoV-2 would lead to fewer cumulative SARS-CoV-2 infections (A) and a lower peak SARS-CoV-2 prevalence (B). Intermediate cross immunity from HCoVs OC43/HKU1 against SARS-CoV-2 leads to high peak prevalence (B) because cross immunity is high enough to push the SARS-CoV-2 peak to the winter, but not high enough to suppress SARS-CoV-2 infection altogether. High R0 and low seasonality are both associated with higher cumulative SARS-CoV-2 infections (C) and higher peak SARS-CoV-2 prevalence (D). Quicklywaning immunity (σ3) is strongly associated with high cumulative SARS-CoV-2 infections (E), while autumn/winter establishment is strongly associated with high peak SARS-CoV-2 prevalence (F). Long incubation and infectious periods are associated with a high cumulative number of infections (G), while epidemic peak size is maximized for short latent periods and long infectious periods (H). Table S8 . Infected individuals then proceed to an exposed (E) state, after which a proportion pR = 0.956 enters the 'recovery' arm, pH = 0.0308 enters the 'hospitalization' arm, and pC = 0.0132 enters the 'critical care' arm. Exposed individuals become infectious (I) at rate ν = 1/4.6 days. Individuals in the recovery arm then recover (R) at rate ! = 1/5 days, but individuals in the hospitalization arm must pass through the hospitalization state (H) and individuals in the critical care arm must pass through both the hospitalization (H) and critical care (C) states. The average duration of hospitalization was 1/dH = 8 days in the hospitalization arm and 1/dC = 6 days in the critical care arm (26) . The average duration of critical care was 1/"C = 10 days (26) . 

H) Figure S16 . Intermittent social distancing scenarios with gamma-distributed waiting times. Intermittent social distancing (shaded blue regions) without seasonal forcing (A, C) and with strong seasonal forcing (f = 0.4, B, D) with gamma-distributed latent period, infectious period, hospitalization period, and critical care period (see Figure S17 ). The on/off thresholds for social distancing are depicted by the dashed horizontal lines. For (A) and (B), the maximal wintertime R0 is 2.2, while for (C) and (D) the maximum wintertime R0 is 2.6. Distancing yields a 60% reduction in R0. Prevalence is in black and critical care cases are in red. To the right of each main plot (E-H), the proportion immune over time is depicted in green with the herd immunity threshold (horizontal black bar). Compared to the model with exponentially-distributed waiting times, incidence rises more sharply when the waiting times are gamma-distributed, requiring a lower threshold to trigger interventions and leading to more frequent interventions.

Figure S17. Comparison of exponential and gamma-distributed waiting times for the intervention model. A) latent period (mean 4.6 days); B) infectious period (mean 5 days); C) Hospitalization period without critical care (mean 8 days); D) Hospitalization period followed by critical care (mean 6 days); E) Critical care period (mean 10 days). The exponentiallydistributed waiting times are depicted in black and the gamma-distributed waiting times, generated by introducing five 'dummy' compartments for each state, are depicted in blue. The means of the distributions are depicted by the dashed vertical line.

of immunity is intermediate (1/σ3 = 104 weeks) and if HCoVs OC43/HKU1 impart intermediate cross immunity against SARS-CoV-2

The demand for inpatient and ICU beds for COVID-19 in the US: lessons from Chinese cities

Italy hospitals at virus limit

COVID-19 infections rise in New York with peak weeks away

Outbreak reporting is expected and respected

Transcript for the CDC Telebriefing Update on COVID-19

The antigenic evolution of influenza: Drift or thrift? Philos

Complete genomic sequence of human coronavirus OC43: Molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event

Epidemiology, genetic recombination, and pathogenesis of coronaviruses

Potential impact of seasonal forcing on a SARS-CoV-2 pandemic

Absolute humidity and the seasonal onset of influenza in the continental United States

Conjunction of factors triggering waves of seasonal influenza

The time course of the immune response to experimental coronavirus infection of man

Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests

An outbreak of human coronavirus OC43 infection and serological cross-reactivity with SARS coronavirus. Can

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention

Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: a modelling study in Hubei, China and northern Italy

Estimates of the severity of COVID-19 disease

Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing

Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts

Institute for Disease Modeling, Bill & Melinda Gates Foundation, Social distancing and mobility reductions have reduced COVID-19 transmission in King County

Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak in China

Impact of nonpharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand

Coronavirus: Thousands of extra hospital beds and staff

Makeshift hospitals for COVID-19 patients: Where health-care workers and patients need sufficient ventilation for more protection

Coronavirus: How can China build a hospital so quickly?

The National Respiratory and Enteric Virus Surveillance System (NREVSS)

Predicting the epidemic sizes of influenza A/H1N1, A/H3N2, and B: A statistical method

Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures

How generation intervals shape the relationship between growth rates and reproductive numbers

Driving factors of influenza transmission in the Netherlands

Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions

The incubation period of Coronavirus Disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application

Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: A statistical analysis of publicly available case data

What is the best control strategy for multiple infectious disease outbreaks?

Modeling the comparative impact of individual quarantine vs. active monitoring of contacts for the mitigation of

Public health interventions and epidemic intensity during the 1918 influenza pandemic

The US 2009 A(H1N1) influenza epidemic: Quantifying the impact of school openings on the reproductive number

Direct measurement of rates of asymptomatic infection and clinical care-seeking for seasonal coronavirus

State of the Tropics 2017 Report: Sustainable Infrastructure in the Tropics

Global spatio-temporal patterns of influenza in the post-pandemic era

Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates

Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)

Understanding SARS-CoV-2-mediated inflammatory responses: From mechanisms to potential therapeutic tools

Open COVID-19 Data Working Group, The effect of human mobility and control measures on the COVID-19 epidemic in China

Influenza seasonality: Lifting the fog

Ten weeks to crush the curve

c2-d2/CoV-seasonality: First release

Transmission dynamics and control of severe acute respiratory syndrome

Comparison of three methods for selecting values of input variables in the analysis of output from a computer code

Medline 61. R Core Team, R: A language and environment for statistical computing (R Foundation for Statistical Computing

Solving differential equations in R: Package deSolve